Yitzhak Zimmer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Palliative Care

Top Venues

Cellular and molecular life sciences : CMLS

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-associated purine synthesis pathway is a major component of the MET-DNA damage response network. Cancer research communications (2024)
Michaela Poliaková Turan, Rahel Riedo, Matúš Medo, Chiara Pozzato, Manja Friese-Hamim, Jonas Paul Koch, Si'Ana A Coggins, Qun Li, Baek Kim, Joachim Albers, Daniel Matthias Aebersold, Nicola Zamboni, Yitzhak Zimmer, Michaela Medová
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network. Cancer research communications 4 (7) (2024)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (4) (2023)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (4) (2023)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (4) (2023)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (1) (2022)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (1) (2022)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (1) (2022)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (1) (2022)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (1) (2022)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (1) (2022)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (1) (2022)
Eleonora Orlando, Matúš Medo, Ariel Bensimon, Aurélie Quintin, Rahel Riedo, Selina M Roth, Carsten Riether, Thomas M Marti, Daniel M Aebersold, Michaela Medová, Ruedi Aebersold, Yitzhak Zimmer
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies. Cellular and molecular life sciences : CMLS 80 (1) (2022)